1230726

GlaxoSmithKline LLC — FEI 1035048

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Durham, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)